Xtra-Gold Reports Voting Results of Annual General Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - June 17, 2024) - XTRA-GOLD RESOURCES CORP. (TSX: XTG) (OTCQB: XTGRF)("Xtra-Gold" or the "Company") - is pleased to announce the voting results of its Annual General Meeting (the "AGM") of shareholders of the Company (the "Shareholders") held on June 14, 2024. A total of 26,626,228 common shares representing 57.763% of the issued and outstanding shares of the Company were voted at the AGM. Resolutions relating to the following matters were approved by a majority of the votes cast at the ASM.
Appointment of Auditors
Reliant CPA PC, Chartered Accountants were appointed as the auditors of the Company for the ensuing year.
Election of Directors
The number of directors to be elected to the board of directors of the Company ("Board") was set at six. The following nominees proposed by management were elected as directors of the Company to hold office until the next annual meeting of Shareholders or until their successors is elected or appointed.
| DIRECTOR | VOTES FOR | % | VOTES WITHHELD | % |
| Peter Minuk | 24,821,422 | 99.99% | 263 | 0.01% |
| James Schweitzer | 24,520,622 | 98.787% | 301,063 | 1.23% |
| James Longshore | 24,821,422 | 99.99% | 263 | 1.05% |
| Denis Laviolette | 24,520,622 | 98.787% | 301,063 | 1.23% |
| Hans Morsches | 24,520,622 | 98.787% | 301,063 | 1.23% |
| Todd Gibson | 24,821,422 | 99.99% | 263 | 0.01% |
Stock Option Plan
The Shareholders voted 97.747% in favor of the amendment to the company's stock option plan to extend the exercise price period following the death of the participant from 1 year to 3 years under the Company's stock option plan.
Contact Information
For further information please contact:
James Longshore: President and CEO
Telephone: 242-363-3864
E-mail: [email protected]
Website: www.xtragold.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/213260
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Starts Assembly Biosciences (ASMB) at Buy
- HSBC Reiterates Buy Rating on Aurobindo Pharma (ARBP:IN)
- Mizuho: 'we believe CMG's cycle of lower margin revisions remains in the rear-view mirror'
Create E-mail Alert Related Categories
Newsfile, Press ReleasesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share